De Pauw, I.; Lardon, F.; Van den Bossche, J.; Baysal, H.; Pauwels, P.; Peeters, M.; Vermorken, J.B.; Wouters, A.
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib. Cancers 2019, 11, 98.
https://doi.org/10.3390/cancers11010098
AMA Style
De Pauw I, Lardon F, Van den Bossche J, Baysal H, Pauwels P, Peeters M, Vermorken JB, Wouters A.
Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib. Cancers. 2019; 11(1):98.
https://doi.org/10.3390/cancers11010098
Chicago/Turabian Style
De Pauw, Ines, Filip Lardon, Jolien Van den Bossche, Hasan Baysal, Patrick Pauwels, Marc Peeters, Jan Baptist Vermorken, and An Wouters.
2019. "Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib" Cancers 11, no. 1: 98.
https://doi.org/10.3390/cancers11010098
APA Style
De Pauw, I., Lardon, F., Van den Bossche, J., Baysal, H., Pauwels, P., Peeters, M., Vermorken, J. B., & Wouters, A.
(2019). Overcoming Intrinsic and Acquired Cetuximab Resistance in RAS Wild-Type Colorectal Cancer: An In Vitro Study on the Expression of HER Receptors and the Potential of Afatinib. Cancers, 11(1), 98.
https://doi.org/10.3390/cancers11010098